Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen Hunt

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Environmental Research and Public Health|January 26, 2020
Predicting Water Cycle Characteristics from Percolation Theory and Observational DataAllen Hunt, Boris Faybishenko, Behzad Ghanbarian, et al.
Clinical Pharmacology in Drug Development|November 16, 2022
Evaluation of Potential Food Effects and Drug Interactions With Lansoprazole in Healthy Adult Volunteers Receiving FutibatinibIkuo Yamamiya, Allen Hunt, Fumiaki Yamashita, et al.
Clinical Pharmacology in Drug Development|June 10, 2023
Evaluation of the Mass Balance and Metabolic Profile of Futibatinib in Healthy ParticipantsIkuo Yamamiya, Allen Hunt, Fumiaki Yamashita, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 8, 2024
Randomized trial of pharmacokinetic and pharmacodynamic effects of 13.2 mg intranasal epinephrine treatment in congestionDavid A Dworaczyk, Allen Hunt, Mike Di Spirito, et al.
Clinical Pharmacology in Drug Development|May 3, 2023
Evaluation of the Cytochrome P450 3A and P-glycoprotein Drug-Drug Interaction Potential of FutibatinibIkuo Yamamiya, Allen Hunt, Toru Takenaka, et al.
Diabetes, Obesity & Metabolism|March 3, 2025
The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjectsYue Liu, Wei Chen, Xuemei He, et al.
British Journal of Clinical Pharmacology|September 29, 2023
Investigation of the absolute bioavailability, mass balance, metabolism, and excretion of the cholesterol 24-hydroxylase inhibitor soticlestat in healthy volunteersWei Yin, T Eric Ballard, Sean Xiaochun Zhu, et al.
Frontiers in Immunology|December 24, 2024
Evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of SM17 in healthy volunteers: results from pre-clinical models and a first-in-human, randomized, double blinded clinical trialGuolin Xu, Sabina Paglialunga, Xuchen Qian, et al.
Clinical Pharmacology in Drug Development|October 30, 2020
A Phase 1 Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK-1654 in Healthy AdultsAntonios O Aliprantis, Dennis Wolford, Luzelena Caro, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Environmental Research and Public Health|January 26, 2020
Predicting Water Cycle Characteristics from Percolation Theory and Observational DataAllen Hunt, Boris Faybishenko, Behzad Ghanbarian, et al.
Clinical Pharmacology in Drug Development|November 16, 2022
Evaluation of Potential Food Effects and Drug Interactions With Lansoprazole in Healthy Adult Volunteers Receiving FutibatinibIkuo Yamamiya, Allen Hunt, Fumiaki Yamashita, et al.
Clinical Pharmacology in Drug Development|June 10, 2023
Evaluation of the Mass Balance and Metabolic Profile of Futibatinib in Healthy ParticipantsIkuo Yamamiya, Allen Hunt, Fumiaki Yamashita, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 8, 2024
Randomized trial of pharmacokinetic and pharmacodynamic effects of 13.2 mg intranasal epinephrine treatment in congestionDavid A Dworaczyk, Allen Hunt, Mike Di Spirito, et al.
Clinical Pharmacology in Drug Development|May 3, 2023
Evaluation of the Cytochrome P450 3A and P-glycoprotein Drug-Drug Interaction Potential of FutibatinibIkuo Yamamiya, Allen Hunt, Toru Takenaka, et al.
Diabetes, Obesity & Metabolism|March 3, 2025
The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjectsYue Liu, Wei Chen, Xuemei He, et al.
British Journal of Clinical Pharmacology|September 29, 2023
Investigation of the absolute bioavailability, mass balance, metabolism, and excretion of the cholesterol 24-hydroxylase inhibitor soticlestat in healthy volunteersWei Yin, T Eric Ballard, Sean Xiaochun Zhu, et al.
Frontiers in Immunology|December 24, 2024
Evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of SM17 in healthy volunteers: results from pre-clinical models and a first-in-human, randomized, double blinded clinical trialGuolin Xu, Sabina Paglialunga, Xuchen Qian, et al.
Clinical Pharmacology in Drug Development|October 30, 2020
A Phase 1 Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK-1654 in Healthy AdultsAntonios O Aliprantis, Dennis Wolford, Luzelena Caro, et al.
Pageof 1